Chemoinformaics analysis of Baicalein-7-Beta-L-Rhamnoside
| Molecular Weight | 416.382 | nRot | 3 |
| Heavy Atom Molecular Weight | 396.222 | nRig | 24 |
| Exact Molecular Weight | 416.111 | nRing | 4 |
| Solubility: LogS | -3.615 | nHRing | 2 |
| Solubility: LogP | 1.838 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 2 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 17 |
| nHA | 9 | APOL | 55.6239 |
| nHD | 5 | BPOL | 26.1401 |
| QED | 0.395 |
| Synth | 3.822 |
| Natural Product Likeliness | 1.922 |
| NR-PPAR-gamma | 0.974 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.594 |
| HIA | 0.574 |
| CACO-2 | -5.783 |
| MDCK | 0.0000115 |
| BBB | 0.035 |
| PPB | 0.868113 |
| VDSS | 0.903 |
| FU | 0.0918637 |
| CYP1A2-inh | 0.059 |
| CYP1A2-sub | 0.085 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.106 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.36 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.186 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.048 |
| CL | 1.846 |
| T12 | 0.505 |
| hERG | 0.021 |
| Ames | 0.575 |
| ROA | 0.067 |
| SkinSen | 0.22 |
| Carcinogencity | 0.716 |
| EI | 0.017 |
| Respiratory | 0.081 |
| NR-Aromatase | 0.889 |
| Antiviral | Yes |
| Prediction | 0.918858 |